KayoThera

About

KayoThera is developing first-in-class, oral and safe antagonists of retinoid signaling, a pathway that was previously thought to be undruggable. KayoThera has developed a pipeline of potent drugs that inhibit retinoid signaling, have superb drug-like properties and excellent safety profile. Our retinoid inhibitors could be a potent and long-lasting option to reverse Type 2 diabetes as well as treat a number of genetically-defined cancers.